Akebia Therapeutics | AKBA - Current Assets


Akebia Therapeutics reported $252.96M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Acadia Pharmaceuticals USD 1.06B 14.31M Dec/2025
Agios Pharmaceuticals USD 834.84M 107.21M Mar/2026
Akebia Therapeutics USD 252.96M 5.38M Dec/2025
Alnylam Pharmaceuticals USD 4.22B 168.65M Mar/2026
Amgen USD 31.48B 2.42B Mar/2026
Ardelyx USD 381.87M 447K Mar/2026
Astellas Pharma JPY 1.42T 19.35B Mar/2026
AstraZeneca USD 29.61B 890M Mar/2026
Bayer EUR 32.91B 30M Dec/2025
BioMarin Pharmaceutical USD 4.61B 651.58M Mar/2026
Celltrion KRW 5.54T 291.68B Sep/2025
Cspc Pharmaceutical CNY 22.25B 359.48M Dec/2025
Deva Holding AS TRY 9.13B 1.61B Sep/2023
Dianthus Therapeutics USD 1.12B 710.47M Mar/2026
Exelixis USD 1.44B 41.03M Dec/2025
Fresenius Medical Care EUR 7.9B 74M Dec/2025
GlaxoSmithKline GBP 17.76B 251M Mar/2026
Ionis Pharmaceuticals USD 2.94B 52M Mar/2026
Ironwood Pharmaceuticals USD 273.84M 82.09M Sep/2025
J&J USD 59.17B 3.55B Mar/2026
Kangmei Pharma CNY 7.03B 128.34M Sep/2025
Karyopharm Therapeutics USD 103.15M 13.4M Dec/2025
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
Laboratorios Farma EUR 509.33M 128.63M Dec/2023
Lexicon Pharmaceuticals USD 101.9M 20.63M Dec/2025
Malin Corporation EUR 62.6M 26.7M Dec/2024
Medical Developments International AUD 33.75M 1.79M Dec/2025
Moderna USD 5.77B 774M Mar/2026
Nektar Therapeutics USD 266.27M 15.09M Dec/2025
Neuren Pharmaceuticals AUD 332.23M 11.98M Dec/2025
Organigram Holdings CAD 256.54M 28.35M Dec/2025
Ovoca Bio EUR 1.56M 3.39M Jun/2025
Pharma Mar EUR 273.45M 9.96M Mar/2026
Prothena USD 315.19M 24.78M Dec/2025
PTC Therapeutics USD 2.27B 266.14M Dec/2025
Qiagen NV USD 2B 535.87M Dec/2025
Regeneron Pharmaceuticals USD 18.21B 187.3M Mar/2026
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.16B 789M Mar/2026
Sarepta Therapeutics USD 2.54B 184.37M Dec/2025
Sartorius EUR 1.92B 157.2M Mar/2026
Sino Biopharmaceutical CNY 33.82B 9.13B Jun/2025
Tectonic Therapeutic USD 257.36M 15.88M Dec/2025
Tilray USD 729.32M 28.18M Sep/2025
Vanda Pharmaceuticals USD 347.26M 20.23M Dec/2025
Zealand Pharma A/S 15.67B 950.94M Dec/2025
Zz Pientze Pharmaceu CNY 11.43B 728.95M Mar/2026